Group One Trading’s Epizyme, Inc EPZM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-2,400
| Closed | -$3K | – | 8871 |
|
|
2022
Q1 | $3K | Hold |
2,400
| – | – | ﹤0.01% | 7687 |
|
|
2021
Q4 | $6K | Sell |
2,400
-30,100
| -93% | -$118K | ﹤0.01% | 7612 |
|
|
2021
Q3 | $166K | Sell |
32,500
-50,000
| -61% | -$304K | ﹤0.01% | 5367 |
|
|
2021
Q2 | $686K | Buy |
82,500
+69,100
| +516% | +$583K | ﹤0.01% | 3859 |
|
|
2021
Q1 | $117K | Buy |
13,400
+8,500
| +173% | +$88K | ﹤0.01% | 5527 |
|
|
2020
Q4 | $53K | Buy |
4,900
+4,200
| +600% | +$51.8K | ﹤0.01% | 4978 |
|
|
2020
Q3 | $8K | Sell |
700
-4,400
| -86% | -$58.9K | ﹤0.01% | 5515 |
|
|
2020
Q2 | $82K | Sell |
5,100
-9,900
| -66% | -$173K | ﹤0.01% | 4062 |
|
|
2020
Q1 | $233K | Sell |
15,000
-46,200
| -75% | -$992K | ﹤0.01% | 2636 |
|
|
2019
Q4 | $1.51M | Buy |
61,200
+44,500
| +266% | +$661K | 0.01% | 1525 |
|
|
2019
Q3 | $172K | Buy |
+16,700
| New | +$211K | ﹤0.01% | 3190 |
|
|
2019
Q2 | – | Sell |
-1,600
| Closed | -$20K | – | 5577 |
|
|
2019
Q1 | $20K | Buy |
+1,600
| New | +$17.9K | ﹤0.01% | 4039 |
|
|
2018
Q4 | – | Sell |
-4,100
| Closed | -$43K | – | 5618 |
|
|
2018
Q3 | $43K | Hold |
4,100
| – | – | ﹤0.01% | 4061 |
|
|
2018
Q2 | $56K | Buy |
4,100
+2,000
| +95% | +$31.1K | ﹤0.01% | 3894 |
|
|
2018
Q1 | $37K | Sell |
2,100
-33,400
| -94% | -$564K | ﹤0.01% | 3798 |
|
|
2017
Q4 | $446K | Buy |
35,500
+25,000
| +238% | +$363K | ﹤0.01% | 2340 |
|
|
2017
Q3 | $200K | Sell |
10,500
-14,900
| -59% | -$227K | ﹤0.01% | 2758 |
|
|
2017
Q2 | $384K | Sell |
25,400
-41,600
| -62% | -$629K | ﹤0.01% | 2168 |
|
|
2017
Q1 | $1.15M | Sell |
67,000
-20,600
| -24% | -$274K | 0.01% | 1249 |
|
|
2016
Q4 | $1.06M | Buy |
+87,600
| New | +$914K | 0.01% | 1286 |
|
|
2016
Q3 | – | Sell |
-2,000
| Closed | -$20K | – | 5036 |
|
|
2016
Q2 | $20K | Buy |
+2,000
| New | +$22.3K | ﹤0.01% | 3808 |
|
|
2016
Q1 | – | Sell |
-100
| Closed | -$2K | – | 5107 |
|
|
2015
Q4 | $2K | Sell |
100
-9,800
| -99% | -$145K | ﹤0.01% | 4554 |
|
|
2015
Q3 | $127K | Buy |
9,900
+8,800
| +800% | +$178K | ﹤0.01% | 2872 |
|
|
2015
Q2 | $26K | Buy |
1,100
+700
| +175% | +$13.5K | ﹤0.01% | 3917 |
|
|
2015
Q1 | $8K | Sell |
400
-100
| -20% | -$2.06K | ﹤0.01% | 4241 |
|
|
2014
Q4 | $9K | Buy |
500
+400
| +400% | +$9.34K | ﹤0.01% | 4282 |
|
|
2014
Q3 | $3K | Sell |
100
-7,300
| -99% | -$227K | ﹤0.01% | 4869 |
|
|
2014
Q2 | $230K | Buy |
+7,400
| New | +$174K | ﹤0.01% | 2278 |
|
Other funds holding EPZM
Group One Trading's EPZM Position: Q3 2022 in Review
Group One Trading sold out of Epizyme, Inc (EPZM) in Q3 2022, closing a stake of 74,339 shares — an estimated $109K sold.
Group One Trading first reported a position in EPZM in Q1 2014 and held it in 19 quarters. The position peaked at $304K in Q1 2014. 0 funds tracked by Wall St. Rank hold EPZM as of Q3 2022.
- Group One Trading reported no remaining Epizyme, Inc position as of Q3 2022 after selling out during the quarter.
- Group One Trading sold 74,339 Epizyme, Inc shares in Q3 2022, an estimated $109K.
- Group One Trading first reported a position in Epizyme, Inc in Q1 2014 and held it in 19 quarters.
- Group One Trading's Epizyme, Inc position peaked at $304K in Q1 2014.
- 0 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2022.
Based on Group One Trading's 13F filing for Q3 2022, filed 9 Nov 2022.